Correlation Between Verrica Pharmaceuticals and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Kymera Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Kymera Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Kymera Therapeutics
0.66 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Verrica and Kymera is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Kymera Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 2.86 times less return on investment than Kymera Therapeutics. In addition to that, Verrica Pharmaceuticals is 1.09 times more volatile than Kymera Therapeutics. It trades about 0.02 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 3,914 in Kymera Therapeutics on October 20, 2024 and sell it today you would earn a total of 147.00 from holding Kymera Therapeutics or generate 3.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Kymera Therapeutics
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Kymera Therapeutics |
Verrica Pharmaceuticals and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Kymera Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |